SCHEMBL7944009

SCHEMBL7944009

C=C1NCc2ccc(OC)cc21

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
METAP1 P53582 2/20 0.50
PDE3B Q13370 2/20 0.45
PDE3A Q14432 2/20 0.45
ACHE P22303 1/20 0.42
CYP19A1 P11511 2/20 0.40
CYP11B2 P19099 2/20 0.40
CA1 P00915 1/20 0.40
CA2 P00918 1/20 0.40
CA4 P22748 1/20 0.40
CA6 P23280 1/20 0.40
ALDH1A1 P00352 3/20 0.39
KDM4E B2RXH2 2/20 0.39
MAPT P10636 1/20 0.39
MPI P34949 1/20 0.39
RYR2 Q92736 2/20 0.39
CYP1A2 P05177 1/20 0.38
CYP2A6 P11509 1/20 0.38
DRD2 P14416 1/20 0.38
DRD1 P21728 1/20 0.38
DRD5 P21918 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31069587 0.82 PDE3B (0.53) METAP1PDE3BPDE3AACHECYP19A1
SCHEMBL2849831 0.82 PDE3B (0.53) METAP1PDE3BPDE3AACHECYP19A1
SCHEMBL8232389 0.76 ALDH1A1 (0.45) METAP1PDE3BPDE3AACHECYP19A1
SCHEMBL13090790 0.76 PARP10 (0.49) METAP1ACHECYP19A1CYP11B2HTR2A
SCHEMBL8227734 0.72 METAP1 (0.49) METAP1ACHECYP19A1CYP11B2ALDH1A1
SCHEMBL10113037 0.71 CLK4 (0.47) METAP1PDE3BPDE3AACHEALDH1A1
SCHEMBL15467555 0.70 METAP1 (0.49) METAP1PDE3BPDE3AACHECA1
SCHEMBL4895916 0.70 METAP1 (0.61) METAP1PDE3BPDE3AACHECYP19A1
SCHEMBL6542702 0.69 NPY5R (0.43) PDE3BPDE3AACHECA1CA2
SCHEMBL246378 0.69 PARP10 (0.63) METAP1ACHECYP19A1ALDH1A1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2010054278-A2 COMPOUNDS FOR THE TREATMENT OF INFLAMMATORY DISORDERS SCHERING CORPORATION (US) 2010-05-14 WO disclosed
WO-2007084455-A1 HYDANTOIN COMPOUNDS FOR THE TREATMENT OF INFLAMMATORY DISORDERS SCHERING CORPORATION (US) 2007-07-26 WO disclosed
WO-2007084451-A1 HYDANTOIN DERIVATIVES FOR THE TREATMENT OF INFLAMMATORY DISORDERS SCHERING CORPORATION (US) 2007-07-26 WO disclosed
WO-2007084415-A2 COMPOUNDS FOR THE TREATMENT OF INFLAMMATORY DISORDERS SCHERING CORPORATION (US) 2007-07-26 WO disclosed